quantitative
Analysis v1
Strong Support
This drug called retatrutide probably helps people with obesity or type 2 diabetes control their blood sugar better, especially if they take a higher dose.
57
0
Evidence from Studies
Supporting (1)
57
Community contributions welcome
57
Efficacy and safety of retatrutide, a novel GLP-1, GIP, and glucagon receptor agonist for obesity treatment: a systematic review and meta-analysis of randomized controlled trials
Systematic Review With Meta-Analysis
Human
2025The study looked at retatrutide in people with obesity or diabetes and found it lowered blood sugar and HbA1c by the exact amounts the claim says, especially with higher doses.
Contradicting (0)
0
Community contributions welcome
No contradicting evidence found
Gold Standard Evidence Needed
According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.